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during neonatal hemolysis in mice
Aleksandra Bednarz1, Paweł Lipiński2, Rafał R. Starzyński2, Mateusz tomczyk3, 
Witold nowak3, olga Mucha3, Mateusz ogórek1, olga Pierzchała1, Aneta Jończy2, 
Robert Staroń2, Julia Śmierzchalska1, Zenon Rajfur4, Zbigniew Baster  4, Alicja Józkowicz3 & 
Małgorzata Lenartowicz1
Moderate intravascular hemolysis is a common condition in newborns. It is followed by the 
accumulation of bilirubin, which is a secondary product of the activity of heme oxygenase-1, an enzyme 
that catalyzes the breakdown of heme released from disrupted erythrocytes and taken up by hepatic 
macrophages. Although these cells are a major site of enzymatic heme breakdown in adults, we show 
here that epithelial cells of proximal tubules in the kidneys perform the functions of both heme uptake 
and catabolism in mouse neonates. A time-course study examining mouse pups during the neonatal 
period showed a gradual recovery from hemolysis, and concomitant decreases in the expression 
of heme-related genes and non-heme iron transporters in the proximal tubules. By adjusting the 
expression of iron-handling proteins in response to the disappearance of hemolysis in mouse neonates, 
the kidneys may play a role in the detoxification of iron and contribute to its recirculation from the 
primary urine to the blood.
In humans, neonatal jaundice is one of the most common pathophysiological conditions, affecting all pre-term 
and a high proportion of term newborns. It is usually due to excessive bilirubin production and/or impaired 
conjugation, resulting in an increased bilirubin concentration. Generally, this is an entirely benign process that 
is resolved by the end of the first week of life without treatment1. Mild intravascular hemolysis is often the pri-
mary cause of hyperbilirubinemia during the first week of life and is a feature of normal newborn physiology2. 
The inevitable nature of neonatal hemolysis is mainly due to the increased red blood cell (RBC) turnover rate in 
newborns, which is up to 2–3 times that of a normal adult3. The reduced neonatal RBC lifespan is thought to be 
caused by the increased oxidant sensitivity of these cells and relative instability of fetal hemoglobin, which may 
entail RBC membrane damage4. The disruption of fetal erythrocytes is associated with the release to the blood-
stream of highly reactive pro-oxidants such as free hemoglobin (Hb) and its porphyrin component, heme. Under 
conditions of limited hemolysis, the potentially deleterious effects of Hb and heme are efficiently counteracted 
by protective systems composed of specific ligands (haptoglobin and hemopexin, respectively) and receptors 
(CD163 and CD91, respectively) that lead to Hb and heme binding, neutralization and clearance, mainly by mac-
rophages of the reticuloendothelial system and hepatocytes5. Subsequent detoxification of heme released from Hb 
in the cellular compartment involves the activity of heme oxygenase 1 (HO1), a key enzyme in heme catabolism 
that cleaves the porphyrin ring, at the expense of molecular oxygen, to release ferrous iron, CO and biliverdin6. 
Freed heme iron is then neutralized by ferritin, a multimeric cytosolic iron-storage protein, or recycled to the 
circulation via ferroportin (Fpn), the sole known iron exporter, while biliverdin is rapidly enzymatically reduced 
to bilirubin7. Hemolysis-dependent overproduction of bilirubin during the neonatal period, in combination with 
its defective metabolism through glucuronidation by developmentally immature UDP-glucuronosyltransferase, 
reduces bilirubin excretion into the bile and predisposes newborns to high total serum bilirubin levels8.
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Figure 1. Markers of hemolysis in the plasma of mouse neonates. (a) Total bilirubin concentration in the 
plasma of mouse neonates and adult (3-month-old) mice. Values are expressed as the means ± S.D. N values 
for each group are: 3dpp = 5, 5dpp = 5, 7dpp = 5, 9dpp = 5, 11dpp = 5, 90dpp = 5. Data set is not normally 
distributed, therefore, nonparametric, Kruskal-Wallis ANOVA was used (p = 0,004, df = 5, H = 17,3). Dunn’s 
Multiple Comparison Test was used as post-hoc test. Plasma levels of hemopexin (Hpx) (b) and haptoglobin 
(Hp) (d) assessed by Western blotting. The blots were reprobed with polyclonal anti-albumin antibody as 
a loading control. Results come from 2 separate blots and relative levels of proteins were standardized to a 
percentage with %S.D. in order to eliminate technical differences between blots. Immunolabeled Hpx (c) and 
Hp (e) and albumin control bands were quantified using a Molecular Imager and the relative levels of the 
test proteins (means ± S.D.) are plotted in arbitrary units. N values in each group for both Hp and Hpx are: 
3dpp = 5, 5dpp = 5, 7dpp = 5, 9dpp = 5, 11dpp = 4. Data set for Hpx has normal distribution, therefore, one-
way ANOVA was used (p < 0.0001, df = 4, F = 51,40). Tukey’s Multiple Comparison Test was used as post-hoc 
test. Data set for Hp is not normally distributed, therefore, Kruskal-Wallis ANOVA was used (p = 0,9622, 
df = 4, H = 0,608) but no statistically significant differences were observed. Capital and small letters over bars 
in the charts (a,c,e) denote significant differences between age groups, with p < 0.01 and p < 0.05, respectively. 
dpp – days postpartum. (f–h) RBC indices potentially indicating the occurrence of hemolysis: (f) RBC- Red 
blood cells count, (g) MCV - mean corpuscular volume of a red blood cell, (h) RDW - red cell distribution 
width. Values are expressed as the means ± S.D. N values for each group are: 3dpp = 6, 5dpp = 5, 7dpp = 5, 
9dpp = 4, 11dpp = 7. Data set for RBC and RDW has normal distribution, therefore, one-way ANOVA was 
used and Tukey’s Multiple Comparison Test was used as post-hoc test for the RBC and post test for linear 
trend (p = 0,0097) was used for RDW. Data set for MCV is not normally distributed, therefore, nonparametric, 
Kruskal-Wallis ANOVA was used. Dunn’s Multiple Comparison Test was used as post-hoc test. Capital and 
small letters over bars in the charts (a,c,f,g,h) denote significant differences between age groups, with p < 0.01 
and p < 0.05, respectively. dpp – days postpartum. (i) Lactate dehydrogenase (LDH2) plasma levels in the serum 
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In many hemolytic disorders, excessive hemolysis may overwhelm endogenous plasma haptoglobin/
hemopexin and other scavenging mechanisms as well as heme degradation pathways in hepatic, splenic and 
bone marrow macrophages. Human9 and animal10,11 studies have clearly shown that under severe hemolytic con-
ditions, the kidneys participate in the management of heme and non-heme iron released from disrupted RBCs. 
There is growing evidence that renal tubular cells can adapt to exposure to high levels of heme by inducing 
HO1 and ferritin9,10. Furthermore, it has been established that these polarized epithelial cells are equipped with 
a competent molecular machinery that allows iron uptake from the primary urine, its transport across the apical 
membrane and finally its redistribution through the basolateral membrane into the circulation12–14.
Most studies on mouse neonatal jaundice have been performed on genetically modified animals showing 
impaired bilirubin conjugation and hyperbilirubinemia, which consequently experience early neonatal lethality 
due to bilirubin toxicity15. Here, our aim was to explore the role of the kidneys in iron handling during natu-
rally occurring neonatal jaundice in mice. We wished to determine whether moderate physiological hemolysis 
in mouse neonates affects iron metabolism in the kidneys. This is of particular importance in the context of 
the developmental delay in early postnatal hepatic iron management16. In humans, the knowledge about the 
involvement of kidneys in neonatal iron metabolism could be also very useful in the treatment of severe cases 
of neonatal jaundice especially in newborns with congenital nephropathies. Our results revealed a gradual dis-
appearance of hemolysis in mice between days 3 and 11 after birth, a phenomenon closely correlated with the 
orchestrated decrease in the expression of HO1 and proteins responsible for apical/basolateral transport of heme 
and non-heme iron in the epithelial cells of kidney proximal tubules. We hypothesize that initially (during the 
first week of life), the presence of high levels of iron-handling proteins in the kidneys in response to hemolysis, 
not only reduces iron toxicity but also contributes to the economical use of this microelement in mouse neonates.
Results
Hyperbilirubinemia and evidence of intravascular hemolysis in neonatal mice. The concentra-
tion of bilirubin in the blood plasma of mice was measured during the neonatal period from day 3 to day 11 after 
birth and in 90-day-old adult mice. Serum bilirubin was more than 2-fold elevated in the neonates compared 
with adults (Fig. 1a). Postnatal instability of fetal erythrocytes and the increased risk of developing intravascular 
hemolysis is usually the initial cause of hyperbilirubinemia during the first week of life2. We therefore studied the 
hallmarks of intravascular hemolysis in mouse neonates, such as hemopexin and haptoglobin (heme and hemo-
globin scavenging proteins, respectively). We also evaluated RBC indices potentially indicating the occurrence 
of hemolysis. Under conditions of increased leakage of heme and/or hemoglobin into the blood, serum levels of 
both proteins are generally low5. We detected an increase in hemopexin in the serum of mouse neonates, with val-
ues measured on days 3 and 11 postpartum differing by more than 3-fold (Fig. 1b,c). In contrast, serum haptoglo-
bin levels remained unchanged throughout the entire neonatal period (Fig. 1d,e). Among mammals, the mouse 
is unique because there is no strict requirement for haptoglobin as a ligand for hemoglobin scavenging from the 
circulation17. As regards RBC parameters, we showed that the RBC count is gradually increased throughout the 
experimental period (Fig. 1f) while mean corpuscular volume (MCV) is linearly decreased (Fig. 1g) and RDW 
values show tendency to decrease (Fig. 1h). Collectively, these data suggest elimination from the circulation of 
fetal RBC characterized by greater cell volume18. It is also confirmed by the results showing that the lactate dehy-
drogenase (LDH2) plasma levels (used as a marker for intravascular hemolysis in neonates19 is high in the 3- and 
5-day-old mice and next decreased with the age of neonates. It indicates on gradual disappearance of hemolysis 
in mouse neonates between days 3 and 11 after birth (Fig. 1i).
increase in Hmox1 gene expression and disappearance of erythroblastic islands in the early 
postnatal liver. In adult mice, heme and hemoglobin released from circulating erythrocytes during hemoly-
sis are scavenged and metabolized by macrophages, including Browicz-Kupffer cells in the liver7. The Hmox1 gene 
encodes HO1, an enzyme that catalyzes the rate-limiting step in the heme degradation pathway, which results in 
the formation of iron, CO and biliverdin6. Hmox1 expression is mainly regulated at the transcriptional level20. We 
showed that the level of HO1 mRNA gradually increases in mice from day 3 to day 11 after birth (Fig. 2a), and 
displayed a opposite tendency to decreasing intensity of hemolysis as determined by the serum hemopexin level 
(Fig. 1b,c).
Although double immunofluorescence analysis of HO1 and the macrophage marker F4/80 in the liver clearly 
showed that HO1 is expressed in Browicz-Kupffer cells, this pattern of expression was only found in macrophages 
at the center of a ring of erythroblasts, so-called erythroblastic islands (Fig. 2b). These central macrophages are 
known to be specialized in providing nutrients to surrounding erythroblasts. Erythroblastic islands are widely 
accepted as morphological units involved in fetal erythropoiesis that are gradually lost from neonatal mouse liv-
ers21, as confirmed in Fig. 2b,c. The disappearance of erythroblastic islands is accompanied by degeneration and 
removal of the central macrophages, as can be clearly seen in liver sections from 11-day-old mice (Fig. 2b). Our 
findings provide a strong indication that liver macrophages are not primarily involved in the breakdown of heme 
derived from hemolyzed erythrocytes.
from all experimental group of neonates analyzed by Western blotting as described in Materials and Methods. 
Lack of LDH2-positive band in the serum of the adult, intact mouse. Prominent immunopositive band is visible 
in the serum from adult phenylhydrazine-treated (PHZ) mouse (positive control). The blots were reprobed with 
polyclonal anti-albumin antibody as a loading control.
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progressive disappearance of megalin-cubilin protein complex from renal proximal tubules 
during the neonatal period. In the kidney, cubilin and megalin are involved in hemoglobin reabsorption 
in the renal proximal tubules22. Using the immunofluorescence (IF) method we found that megalin and cubilin 
are expressed in the renal cortical tubules of mouse neonates from all age groups (Fig. 3a,b). More precisely we 
showed that both megalin and cubilin are present in epithelial cells of the renal cortex and are localized in the api-
cal region (Fig. 3a). We observed a relatively strong staining of megalin-cubilin complex in cortical renal tubules 
in mice on days 3, 5 and 7 postpartum. In 9- and 11-day-old mice the immunopositive IF signal was much weaker. 
(Fig. 3b). High expression of megalin-cubilin complex in the apical membrane of the proximal tubules of mouse 
neonates during first week of life strongly suggests its involvement in cellular reabsorption of hemoglobin during 
neonatal hemolysis.
Progressive disappearance of HRG1 protein from renal proximal tubules during the neonatal 
period. HRG1, the mammalian homolog of the C. elegans heme transporter23, has been identified as a protein 
that transfers heme across the phagosomal membrane to the cytosol within erythrophagocytosing macrophages24. 
HRG1 has also been detected on the apical membrane of duodenal enterocytes in piglets fed hemoglobin25. To 
assess the potential involvement of HRG1 in the transport of heme from the primary urine under conditions of 
neonatal hemolysis, we examined its localization and expression in the kidney. Immunofluorescence analysis 
revealed that HRG1 is present in epithelial cells of the renal cortex and is localized in apical/sub-apical regions 
(Fig. 4a). To determine the precise location of HRG1 in the nephron, we performed double immunolocalization 
with aquaporin 1 (AQP1), a specific marker for proximal tubules26. Tight co-localization of HRG1 and AQP1 
was identified, which indicates that during the neonatal period, HRG1 is expressed in the proximal renal tubules 
(Fig. 4b). Time-course immunofluorescence (Fig. 4a) and Western blot (Fig. 4c,d) analyses of HRG1 levels 
Figure 2. Increase in Hmox1 gene expression and disappearance of erythroblastic islands in the liver of mice 
during the neonatal period. (a) RT-qPCR analysis of HO1 transcript levels in the liver of mouse neonates from 
3 to 11 days old. The histogram displays the relative HO1 mRNA levels in arbitrary units (means ± S.D.). N 
values for each group are: 3dpp = 5, 5dpp = 5, 7dpp = 4, 9dpp = 4, 11dpp = 5. Data set for Hmox1 expression 
has normal distribution, therefore, one-way ANOVA was used (p = 0,0098, df = 4, F = 4, 6). Tukey’s Multiple 
Comparison Test was used as post-hoc test. Capital letters denote significant differences between the age 
groups, with p < 0.01. (b) Immunofluorescent staining of HO1 (red channel) and co-localization of HO1 with 
F4/80, a macrophage marker (green channel) in the livers of neonatal mice, analyzed by confocal microscopy. 
Hematopoiesis centers in the liver are surrounded by dotted white lines. Cell nuclei were counterstained with 
DAPI (blue). Scale bars correspond to 10 µm. To confirm the specificity of HO1 and F4/80 detection, liver 
sections were incubated only with the mixed secondary antibodies (negative control). (c) Hematoxylin/eosin 
staining of liver sections. Hematopoietic centers present in liver are visible as groups of cells with intensely 
stained cell nuclei. Scale bars correspond to 50 µm in the main images, and to 20 µm in the magnified inserts. 
dpp – days postpartum.
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between days 3–11 after birth clearly showed the progressive loss of this protein, suggesting its decreasing role in 
the transport of free heme from primary urine as hemolysis is reduced. Both localization of HRG1 on the epithe-
lium of proximal tubules and its age-dependent expression pattern strongly suggest the active participation of this 
heme transporter in the clearance of heme from the primary urine during neonatal hemolysis in mice.
Progressive disappearance of TfR1 and DMT1 proteins from neonatal renal proximal tubules. 
During hemolysis, disrupted erythrocytes are a source of both non-heme and heme iron that leaks into the blood. 
Free iron ions are then rapidly bound by apo-transferrin and in complex with this protein they may be filtered out 
Figure 3. Immunofluorescent (IF) localization of megalin-cubilin complex in the renal proximal tubules of 
mice during the neonatal period. (a) IF staining of megalin (red channel) and cubilin (green channel) in the 
kidney of the 3-day-old mouse, analyzed by confocal microscopy, reveals that both transporters have apical 
localization in the epithelial cells of cortical renal tubules. Cell nuclei were counterstained with DAPI (blue). 
Scale bars correspond to 20 µm. (b) IF staining of megalin-cubilin complex in the kidneys of the 3-, 5-, 7-, 
9- and 11-day old neonatal mice. analyzed by confocal microscopy, reveals that both transporters have apical 
localization in the epithelial cells of cortical renal tubules. Cell nuclei were counterstained with DAPI (blue). 
To confirm the specificity of megalin and cubilin detection, kidney sections were incubated only with the 
secondary antibodies (negative control). Scale bars correspond to 20 µm.
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by glomeruli27, which show increased permeability in the neonatal period28. Diferric transferrin then binds to the 
high-affinity Tf receptor 1 (TfR1), present at the apical membrane of epithelial cells in the proximal tubules, and 
is reabsorbed from primary urine via TfR1-mediated endocytosis29. Transport of iron from the endosome to the 
cell cytosol is mediated by DMT130. We analyzed renal expression and localization of TfR1 and DMT1 in mice 
throughout the neonatal period from day 3 to day 11 after birth. The greatest abundance of these proteins was 
found on the apical membrane of epithelial cells of cortical renal tubules in 3-day-old mice (Fig. 5a,b). Expression 
was then progressively reduced so that both proteins became almost undetectable in 9–11-day-old animals. We 
also observed DMT1 in intracellular vesicles of epithelial cells (Fig. 5b). This pattern of localization suggests that, 
according to a well-characterized mechanism, DMT1 participates in the transport of iron freed from transferrin 
within the endosome to the cytoplasm. Collectively, our results support the role of elemental iron importers in the 
uptake of non-heme iron by epithelial cells of proximal tubules from the primary urine during neonatal hemolysis 
in mice.
Decrease in Hmox1 gene expression and HO1 protein in neonatal renal proximal tubules. 
Hemolytic disorders are known to induce Hmox1 expression in the kidney in both adult humans9,10 and labora-
tory animals11. Therefore, we examined whether under conditions of moderate hemolysis, the production of HO1 
is up-regulated in the kidney of mouse neonates, especially since we demonstrated the increased molecular renal 
potential to take up heme (a strong inducer of Hmox1) from primary urine (Fig. 4). RT-qPCR analysis showed 
that an initially high level of the HO1 transcript on day 3 after birth was reduced by about half on successive days 
to attain a significantly lower level on day 11 (Fig. 6a) and displayed a similar tendency as decreasing intensity 
of hemolysis. Immunofluorescence analysis of transverse kidney sections showed a strong HO1 protein signal 
Figure 4. Immunofluorescent (IF) localization and quantitative analysis of heme-responsive gene 1 (HRG1/
Slc48a1), a heme transporter, in the renal proximal tubules of mice during the neonatal period. (a) IF staining 
of HRG1/Slc48a1 (red channel) in the kidneys of mouse neonates, analyzed by confocal microscopy, reveals its 
apical and sub-apical localization in the epithelial cells of cortical renal tubules. Cell nuclei were counterstained 
with DAPI (blue). Scale bars correspond to 20 µm in the main images, and to 10 µm in the magnified insert. To 
confirm the specificity of HRG1/Slc48a1 detection, kidney sections were incubated only with the secondary 
antibody (negative control). (b) IF co-localization of HRG1/Slc48a1 (red channel) and aquaporin 1 (AQP1), a 
proximal tubule marker (green channel) in the kidneys of a 3-day old mouse. Cell nuclei were counterstained 
with DAPI (blue). Scale bars correspond to 20 µm. (c) Renal levels of HRG1/Slc48a1 assessed by Western 
blotting. The blot was reprobed with monoclonal anti-actin antibody as a loading control. (d) Immunolabeled 
HRG1/Slc48a1 and actin control bands were quantified using a Molecular Imager and the relative levels 
of HRG1/Slc48a1 (means ± S.D.) are plotted in arbitrary units (a.u). Results come from 2 separate blots 
and relative levels of proteins were standardized to a percentage with %S.D. in order to eliminate technical 
differences between blots. N values for each group are: 3dpp = 5, 5dpp = 5, 7dpp = 5, 9dpp = 5, 11dpp = 4. 
Data set for HRG1/Slc48a1 has normal distribution, therefore, one-way ANOVA was used (p = 0,0098, df = 4, 
F = 4,521). Tukey’s Multiple Comparison Test was used as post-hoc test. Small letters over the bars in the chart 
denote significant differences between age groups, with p < 0.05. dpp – days postpartum.
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in cortical renal tubules on days 3 and 5 postpartum, but this had almost disappeared in 9- and 11-day-old mice 
(Fig. 6b). Exactly the same pattern of HO1 expression was seen in the epithelial cells of renal tubules examined 
at high magnification (Fig. 6c). Co-localization analysis revealed an overlap in the staining of HO1 and AQP1, 
indicating that similarly to HRG1, HO1 is expressed in the epithelial cells of the proximal renal tubules. The pat-
tern of HO1 expression was corroborated by Western blot analysis of renal membrane extracts, which showed a 
progressive decrease in HO1 protein abundance between days 3–11 (Fig. 6e,f). In the view of these results, HO1 
located in the epithelial cells of proximal tubules is mainly responsible for the breakdown of heme taken up from 
the primary urine during neonatal hemolysis in mice.
Iron status in the neonatal kidneys. HO1-mediated heme breakdown results in the release of ferrous 
iron, which is a strong inducer of ferritin expression31. Ferritin is a cytosolic protein with a high capacity to 
store potentially toxic iron, and thus plays a vital cytoprotective role32. We used Western blotting to analyze the 
renal level of the H-ferritin subunit (H-Ft) possessing ferrooxidase activity, which is crucial for the incorporation 
of iron into the ferritin molecule33. Determination of H-Ft protein levels in the kidneys of 3–9-day-old mice, 
revealed a pattern of decreasing expression similar to HO1, suggesting tight cooperation between these two pro-
teins in detoxifying both heme and non-heme iron (Fig. 7a,b). A slight increase in the level of H-Ft in 11-day-old 
mice appeared to be related to developmental changes in the systemic iron metabolism of this species34. Iron 
complexed with ferritin can be readily detected by histochemical analysis, i.e. by staining tissue sections with 
Perls’ Prussian blue, which results in the appearance of blue deposits. We used this method to examine kidneys 
from mouse neonates but failed to detect iron deposits in kidney sections across the renal cortex (Fig. 7c). These 
results suggest that while H-Ft is induced in the kidney during neonatal hemolysis, it does not form iron deposits 
because the released iron is expelled from the cells via ferroportin.
Hepcidin-independent progressive decrease in ferroportin level in renal proximal tubules during 
the neonatal period. Ferroportin (Fpn), the sole iron exporter known to date, is mainly expressed in duode-
nal enterocytes and macrophages35. However, it has also been detected in proximal tubule cells in both rat36 and 
mouse kidney37. It has been proposed that by transporting iron across the basolateral membrane of tubular cells 
to the blood Fpn is involved in the traffic of iron reabsorbed from the primary urine12. We therefore examined 
the expression and localization of Fpn as a plausible final element in the transport of iron across renal proximal 
Figure 5. Immunofluorescent (IF) localization of transferrin receptor 1 (TfR1) and divalent metal transporter 1 
(DMT1) proteins in the kidneys of mice during the neonatal period. (a) IF staining of TfR1 (red channel) in the 
kidneys of mouse neonates analyzed by confocal microscopy. Expression of TfR1 was detected in cytoplasmic 
vesicles located in the epithelial cells of cortical renal tubules (insert). A positive signal for TfR1 is visible only 
in 3- and 5-day-old mice. (b) IF staining of DMT1 (red channel) in the kidneys of mouse neonates analyzed 
by confocal microscopy. Expression was detected at the apical membrane of epithelial cells of the cortical renal 
tubules (insert and arrows) and in vesicles present in the cytoplasmic compartment (arrowheads). Apical 
localization of DMT1 was found only in kidneys of 3- and 5-day-old mice, whereas vesicular localization was 
detected in kidneys of 3-, 5- and 7-day old-mice. Cell nuclei were counterstained with DAPI (blue). To confirm 
the specificity of TfR1 and DMT1 detection, kidney sections were incubated with only the secondary antibody 
(negative control). Scale bars correspond to 20 µm in the main images, and to 10 µm in the magnified inserts.
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tubules during the neonatal hemolysis period. Immunofluorescent detection of Fpn in mouse neonate kidney sec-
tions (Fig. 8a) followed by quantitative analysis of the fluorescent signal, showed a decrease in abundance (with the 
highest and lowest levels on days 3 and 11, respectively) (Fig. 8b), which mirrored that observed for the other iron 
and heme transporters and HO1 (Figures 1–6). Magnification of IF-stained renal cross-sections through the first 
part of the nephron revealed that Fpn is expressed in the proximal tubules (Fig. 8c). To investigate the potential role 
of hepcidin, (liver-derived peptide that binds to Fpn, and induces its degradation13) in the regulation of Fpn protein 
level on the basolateral membrane of tubular cells we measured hepcidin mRNA abundance in the liver during 
the neonatal period. Our results indicate that gradual decrease in Fpn in the kidneys of mouse neonates is largely 
hepcidin-independent (Fig. 8d). Based on our results, Fpn is a candidate protein charged to remove excess iron from 
epithelial cells of proximal tubules into the bloodstream during neonatal hemolysis in mice.
Discussion
Over the last 10 years, it has become apparent that the kidneys play an important role in systemic iron metabo-
lism12. The renal tubular epithelial cells are thought to represent novel iron storage and recycling sites. Indeed, 
these cells are equipped with the molecular machinery necessary for the detoxification of heme and non-heme 
iron as well as the vectorial transport of this microelement across the proximal tubule epithelium13,14,38. 
Figure 6. Immunofluorescent (IF) localization and quantitative analysis of heme oxygenase 1 (HO1) in the 
renal proximal tubules of mice during the neonatal period. (a) RT-qPCR analysis of HO1 transcript levels in 
the kidneys of mouse neonates from 3 to 11 days old. The histogram displays relative HO1 mRNA levels in 
arbitrary units (means ± S.D.). N values for each group are: 3dpp = 5, 5dpp = 4, 7dpp = 4, 9dpp = 4, 11dpp = 4. 
Data set for Hmox1 expression has normal distribution, therefore, one-way ANOVA was used (p = 0,0101, 
df = 4, F = 4,569). Tukey’s Multiple Comparison Test was used as post-hoc test. (b) IF staining of HO1 in 
transverse sections of kidneys from mouse neonates. HO1 is exclusively expressed in the renal cortex. Scale bars 
correspond to 500 µm. (c) IF staining of HO1 (red channel) shows cytoplasmic protein localization in epithelial 
cells of the cortical renal tubules. Cell nuclei were counterstained with DAPI (blue). To confirm the specificity of 
HO1 detection, kidney sections were incubated with only the secondary antibody (negative control). Scale bars 
correspond to 20 µm. (d) IF co-localization of HO1 (red channel) and AQP1, a proximal tubule marker (green 
channel) in the kidney of a 3-day-old mouse. Cell nuclei were counterstained with DAPI (blue). The scale bar 
corresponds to 20 µm. (e) Levels of HO1 assessed in renal membrane extracts by Western blotting. The blot was 
reprobed with monoclonal anti-actin antibody as a loading control. (f) Immunolabeled HO1 and actin control 
bands were quantified using a Molecular Imager, and the relative levels of HO1 (means ± SD) are plotted in 
arbitrary units (a.u). Results come from 2 separate blots and relative levels of proteins were standardized to a 
percentage with %S.D. in order to eliminate technical differences between blots. N values for each group are: 
3dpp = 5, 5dpp = 5, 7dpp = 5, 9dpp = 5, 11dpp = 4. Data set for HO1 has normal distribution, therefore, one-
way ANOVA was used (p = 0,0039, df = 4, F = 5,564). Tukey’s Multiple Comparison Test was used as post-hoc 
test. Capital letters over the bars in charts (a) and (f) denote significant differences between age groups, with 
p < 0.01. dpp – days postpartum.
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Furthermore, the iron metabolism in the kidneys is regulated systemically13 and locally39 by hepcidin and intra-
cellularly by iron regulatory proteins29. Numerous examples from human patients9 and experimental animals10,11 
provide evidence of the involvement of the kidneys in handling iron entering the circulation as a result of intra-
vascular hemolytic disorders. Under these conditions, hemoglobin (Hb), a highly reactive pro-oxidant and poten-
tially toxic species, is released from ruptured erythrocytes into the blood plasma. In most mammals toxicity of 
free Hb is efficiently neutralized by a multicomponent molecular mechanism composed of haptoglobin (Hp), 
Figure 7. Changes in H-ferritin (H-Ft) protein level and the absence of iron deposits in the kidneys of mice 
during the neonatal period. (a) Levels of H-Ft assessed in renal cytosolic extracts by Western blotting. The 
blot was reprobed with monoclonal anti-actin antibody as a loading control. (b) Immunolabeled H-Ft and 
actin control bands were quantified using a Molecular Imager and the relative levels of H-Ft (means ± S.D.) 
are plotted in arbitrary units (a.u). Results come from 2 separate blots and relative levels of proteins were 
standardized to a percentage with %S.D. in order to eliminate technical differences between blots. N values for 
each group are: 3dpp = 5, 5dpp = 5, 7dpp = 5, 9dpp = 5, 11dpp = 4. Data set for H-Ft has normal distribution, 
therefore, one-way ANOVA was used (p = 0,0014, df = 4, F = 6,849). Tukey’s Multiple Comparison Test was 
used as post-hoc test. Capital letters over the bars in the chart denote significant differences between age groups, 
with p < 0.01. (c) Histological examination of iron loading in the kidneys of mouse neonates. No non-heme 
iron deposits were detected by staining with Perls’ Prussian Blue. Kidney section from 250-day-old HO1 knock-
out mouse was used as a positive control of iron loading in renal cortex (indicated by arrows) during excessive 
hemolysis37. dpp – days postpartum.
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a high-affinity Hb-binding protein and CD163, a scavenger receptor of the Hb-Hp complex present on mac-
rophages/monocytes40. However, when endogenous Hp is depleted by accelerated hemolytic conditions, free Hb 
traverses the glomerular filtration barrier and appears in the urinary space from where it is endocytosed and 
metabolized by the renal proximal tubules. Interestingly, CD163-mediated scavenging of Hb in mice is largely 
independent of Hp-Hb complex formation17.
In this study, taking into account both the increased RBC breakdown in neonates (the primary cause of biliru-
binemia in this group)2 and the functional immaturity of neonatal liver to cope with a hemolytic insult21, we used 
mouse neonates aged between 3- and 11-days-old to investigate the impact of increased neonatal hemolysis on 
the expression of iron-handling proteins in the mouse kidney. Over the period covered by the study, the neonatal 
mice showed increased serum bilirubin, a useful marker of accelerated RBC damage2. To our knowledge, this is 
the first description of the day-by-day serum bilirubin concentration in newborn mice, thereby confirming the 
Figure 8. Immunofluorescent (IF) localization and quantitative analysis of ferroportin (Fpn) in the kidneys 
of neonatal mice combined with quantitative expression analysis of Hamp gene in livers of experimental mice. 
(a) IF staining of Fpn (red channel) in the epithelial cells of cortical renal tubules of mouse neonates, analyzed 
by confocal microscopy. A positive signal is visible on the basolateral membrane of renal cortex epithelial 
cells in 3- (magnified insert), 5- and 7-day-old mice. Cell nuclei were counterstained with DAPI (blue). To 
confirm the specificity of Fpn detection, kidney sections were incubated only with the secondary antibody 
(negative control). Scale bars correspond to 20 µm in the main images, and to 10 µm in the magnified insert. 
(b) Quantitative analysis of the Fpn fluorescent signal in renal cortical tubules. The mean fluorescence signal 
associated with Fpn in each tubule section was measured by ImageJ analysis (3 individuals per age group, 10 
measurements per individual, N = 30 per each age group) and quantified manually as a Mean Grey Value, 
the intensities (means ± S.D.) are plotted in arbitrary units (a.u). Data set for Fpn is not normally distributed, 
therefore, nonparametric, Kruskal-Wallis ANOVA was used (p < 0.0001, df = 4, H = 125,4). Dunn’s Multiple 
Comparison Test was used as post-hoc test. (c) Basolateral Fpn localization in the initial segment of the nephron 
(arrow) reveals that this protein is present in the proximal renal tubules. Cell nuclei were counterstained with 
DAPI (blue). The scale bar corresponds to 20 µm. (d) RT-qPCR analysis of Hamp transcript levels in the livers 
of mouse neonates from 3 to 11 days old. The histogram displays relative Hamp mRNA levels in arbitrary 
units (means ± S.D.). N values for each group are: 3dpp = 4, 5dpp = 5, 7dpp = 4, 9dpp = 4, 11dpp = 4. Data 
set for Hamp expression is not normally distributed, therefore, nonparametric, Kruskal-Wallis ANOVA was 
used (p = 0,0053, df = 4, H = 14,74). Dunn’s Multiple Comparison Test was used as post-hoc test. Capital and 
small letters over bars in the charts (b,d) denote significant differences between age groups, with p < 0.01 and 
p < 0.05, respectively. dpp – days postpartum.
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occurrence of physiological bilirubinemia in the neonatal period. The intensity of this bilirubinemia was much 
lower than that induced in genetically modified animals with impaired neonatal bilirubin conjugation15. RBC 
indices show gradually decreasing hemolysis of fetal erythrocytes and thus reflects developmental trends for 
newborn healthy mice described by others18. The extent of intravascular hemolysis can also be evaluated by the 
depletion of plasma hemopexin (Hx), a plasma glycoprotein able to bind heme with high affinity and transport it 
to the liver for catabolism5,41. We therefore additionally diagnosed hemolysis in newborn mice by measuring the 
plasma Hx level and showed its progressive increase during the neonatal period, indicating the gradual recovery 
of the animals from hemolysis. Gradual disappearance of hemolysis in mouse neonates between days 3 and 11 
after birth was also confirmed by decreasing level of LDH2 in the serum19. In adult mice, liver is the main site of 
final Hb and heme detoxification in a process involving the catalytic activity of HO1, encoded by the Hmox1 gene, 
which is transcriptionally upregulated by a number of stimuli including heme6. We found that the age-dependent 
rise in hepatic HO1 mRNA level displayed an opposite tendency to intensity of hemolysis in mouse neonates. 
This strongly suggests that the liver is not the primary site of HO1-mediated removal of toxic heme from the 
circulation. The HO1 protein in mouse neonatal liver seems to be mainly localized within macrophages in the 
so-called erythroblastic islands, composed of a central macrophage and surrounding erythroblasts, and widely 
accepted as the morphological units responsible for fetal erythropoiesis21. HO1 activity in these macrophages 
may be associated with the progressive degradation of these erythroblastic islands during the neonatal and early 
postnatal periods21.
The demonstration of the decreased capacity of the liver to detoxify hemoglobin and heme released during 
hemolysis in mouse neonates prompted us to investigate the role of the kidney in this function. Earlier plasma 
clearance studies in mice showed the rapid elimination of Hb from the circulation, with the highest uptake by 
the kidney and liver17. Hb, if not bound by Hp, readily passes through the glomerular filter to enter the primary 
urine, from where it is rapidly cleared by the renal proximal epithelium5,41 via the multi-ligand hetero-dimeric 
receptor-complex megalin/cubilin42. Renal uptake of hemoglobin by megalin/cubilin complex has been reported 
in hemolytic conditions43. Herein, we demonstrate for the first time that the expression of these two receptors in 
renal proximal tubules gradually decreases with age in mouse neonates, suggesting their involvement in cellular 
reabsorption of hemoglobin during neonatal hemolysis.
It is known that extracellular Hb undergoes oxidation to higher oxidation states such as metHb, which read-
ily releases heme molecules44. By sequestering Hb-derived heme within a protein complex, Hx prevents its 
pro-oxidant and pro-inflammatory effects and promotes its detoxification. The crucial role of Hx in preventing 
severe renal damage following hemolytic processes has been clearly demonstrated in Hx knock-out mice45.
Substantial changes in renal iron metabolism following exposure to heme and non-heme iron caused by acute 
hemolytic disorders have been well documented in patients9 and experimental animals10,11. However, despite 
the induction of antioxidant cytoprotective proteins such as HO1 and ferritin (Ft), the kidneys remain sensitive 
targets of iron toxicity following exposure to hemoglobin and heme during hemolytic anemias46,47. Here, we 
showed that mild hemolysis in mouse neonates, which occurs without anemia, results in substantial remodeling 
of the renal iron metabolism, which is most intense in 3-day-old mice and then gradually disappears in older 
animals, concomitantly with the decline in hemolysis. We hypothesize that, in addition to loading of the kidney 
with heme iron complexed with Hb, free Hb-derived heme is directly taken up from the tubular lumen via a 
pathway involving HRG1. HRG1 was identified as the main importer of exogenous heme in Caenorhabditis ele-
gans, a heme auxotrophic nematode23. In addition, HRG1 localized on the phagosomal membrane was found to 
transport heme from the phagolysosome to the cytosol of mouse macrophages during erythrophagocytosis48. The 
role of HRG1 in heme-iron recycling has recently been further demonstrated during hemolysis in the zebrafish 
kidney, the major organ for erythrophagocytosis49. In the present study, we have demonstrated for the first time 
that HRG1 is expressed on the apical membrane of proximal tubular epithelial cells in mouse kidney. The level 
of HRG1 expression at this location decreased with age in mouse neonates and was tightly correlated with the 
retreat of hemolysis, suggesting a role for HRG1 in the transport of heme from the proximal tubular lumen to the 
proximal epithelium.
In recent years, it has become clear that transferrin (Tf)-bound iron may be filtered by the glomerulus into 
the tubular lumen27 and may subsequently be completely reabsorbed from the primary urine by TfR1-mediated 
endocytosis29. Successive transport of iron from the endosome to the cell cytosol is mediated by DMT129. We 
showed that both proteins involved in the transport of non-heme iron are highly expressed in the epithelial 
tubular cells of 3–5-day-old mice. This indicates that under conditions of accelerated defense in cells and tissues, 
including the kidneys, loaded with heme iron50. Increases in both the HO1 mRNA and protein in renal tissue has 
been reported in various hemolytic conditions9–11. Our comprehensive analysis of HO1 expression and locali-
zation in the kidneys of mouse neonates demonstrated a marked induction of both the transcript and protein 
in 3-day-old mice. HO1 expression occurred at defined locations throughout the renal cortex. More precisely, 
the epithelial cells of proximal tubules were identified as the principal cells expressing HO1, which corresponds 
to the typical renal localization observed in hemolytic syndromes9–11,50. The time-course of the disappearance 
of renal HO1 expression in mouse neonates displayed a similar tendency as decreasing intensity of hemolysis, 
which supports a protective role for this enzyme during neonatal hemolysis. As originally demonstrated by Balla 
et al.32, in mouse endothelium HO1 acts in concert with ferritin for the efficient detoxification of both heme and 
non-heme iron. HO1-mediated heme breakdown is followed by the induction of ferritin, which binds and neu-
tralizes potentially toxic heme-derived iron. The cooperation between these proteins has been well established in 
cellular and in vivo models31. Systemic knockout in mice of either the Hmox1 gene37 or a proximal tubule-specific 
knock-out of the H-Ft gene51 (encoding the ferritin heavy chain)33 resulted in severe injury of the kidneys. The 
age-dependent renal expression pattern of H-Ft protein in mouse neonates strongly resembles that of HO1, which 
underscores the protective HO1/H-Ft partnership that is active during neonatal hemolysis. Iron-regulated induc-
tion of ferritin expression in hemolytic disorders is usually associated with an increased amount of iron stored 
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in a non-toxic form within ferritin molecules. However, in contrast to a congenital erythropoietic porphyria, a 
chronic mouse model of hemolytic disorder43, we failed to detect any rise in iron content in the kidneys of mouse 
neonates by staining renal sections with Prussian blue, even during the period of highest hemolysis (days 3–7 
after birth). Although this lack of staining does not exclude limited iron accumulation in ferritin (which is below 
the detection limit of the method), it certainly excludes the occurrence of heavy iron deposits observed in the 
kidneys during pathological hemolytic conditions9–11,50. The absence of this phenomenon may reflect the moder-
ate nature of neonatal hemolysis in newborn mice and also the very high up-regulation of ferroportin (the main 
iron export protein), leading to increased efflux of iron from the proximal tubule epithelium into the circulation. 
Indeed, we found that ferroportin is mainly localized on the basolateral membrane of proximal epithelial tubule 
cells, which supports its function as an iron exporter. This basolateral localization of ferroportin was previously 
described in both rat36 and mouse37 kidney. It is noteworthy that the neonatal pattern of Fpn expression in the 
renal proximal tubule epithelium matches the expression pattern of other iron- and heme-related proteins ana-
lyzed in this study. Increase in protein abundance of Fpn, HO1 and ferritin in the cortical part of the kidney was 
reported in adult mice with severe hemolytic disorder such as congenital erythropoietic porphyria43. Interestingly, 
it appears that renal Fpn expression in mouse neonates is not systematically regulated by hepcidin, similarly to 
previous reports52,53, as hepatic expression of the Hamp gene was induced only on day 3 postpartum and during 
consecutive days of neonatal period was barely detectable. Hepcidin expression was also reduced in the hemolytic 
disease mentioned above and in this particular pathology down-regulation of hepcidin was associated with the 
erythropoiesis-induced expression of Fam132b gene encoding erythroferrone, a known suppressor of hepcidin 
synthesis54. The pattern of decreased Fpn expression in the kidney of mouse neonates strongly suggests that it is 
mainly regulated by weakening intracellular signal strength from non-heme and heme iron55.
Taken together, the findings of this study provide evidence that the proximal epithelial tubule cells of mouse 
neonates are equipped with a powerful molecular machinery for the efficient recovery of heme and non-heme 
iron from the primary urine, its intracellular detoxification, and the redistribution of non-heme iron to the blood 
plasma. During the period of neonatal hemolysis, in a situation of temporary physiological liver failure, the kid-
neys play a vital role in iron detoxification and recycling in the body. The latter function is crucial for preventing 
the loss of iron from the organism. The part played by the kidneys in favoring iron retention in the body of neo-
nates helps to balance the demand for this microelement for erythropoiesis and other iron-dependent processes. 
This is particularly important given that the supply of exogenous iron is inadequate in the neonatal period due to 
the well-known functional immaturity of the molecular mechanisms of iron absorption56.
Materials and Methods
Animals. The mice derived from an outbred colony, bred in the Department of Genetics and Evolution, 
Jagiellonian University. We examined 3-, 5-, 7-, 9- and 11-day-old male mice, with the day of birth counted as 
day 1. Up to the day of sacrifice all pups stayed with their mothers. Some experiments were performed on adult, 
90-day-old males. All mice were housed at constant temperature (22 °C) under artificial light (12-hour photoper-
iod). The mothers and adult mice received a standard diet (Labofeed H, Kcynia, Poland) and water ad libitum. 
Neonatal mice were sacrificed by decapitation, while adult mice were sacrificed by isoflurane (Baxter) overdose. 
All animal procedures were in accordance with Guide for the Care and Use of Laboratory Animals (Directive 
2010/63/EU of European Parliament). However, as the only procedure used in this work was post mortem tissue 
collection we have got an approval of the First Local Ethical Committee on Animal Testing at the Jagiellonian 
University in Krakow (permission number: 136/2015).
Sample collection. Blood samples were taken from neonates using heparinized tips or from the inferior 
vena cava of adult males using heparin-coated syringes. The blood was collected in heparin-coated tubes and cen-
trifuged at 800 g/4 °C/10 min. Plasma samples were then frozen in liquid nitrogen and stored at −80 °C for further 
analysis. Renal and hepatic samples were frozen immediately after the dissection. Tissue samples for immunoflu-
orescence analysis were fixed in 4% paraformaldehyde in PBS. For the preparation of paraffin-embedded sections, 
livers were fixed in Bouin’s solution for 24 h.
Measurement of plasma bilirubin concentration. Samples of frozen blood plasma from neonatal and 
adult males were thawed on ice and centrifuged at 800 g/4 °C/10 min. Total bilirubin (T-Bil) concentrations were 
measured using SPOTCHEM Total Bilirubin reagent strips with a SPOTCHEM EZ SP-4430 biochemical analyser 
(Arkray) according to the manufacturer’s instructions.
Hematological parameters measurements. Blood samples were collected to heparin-coated tubes and 
kept on ice. Red blood cells count (RBC), mean corpuscular volume of a red blood cell (MCV) and red cell dis-
tribution width (RDW) were measured using a hematology analyser (ABC Vet Animal Blood Counter, Horiba 
ABX) according to the manufacturer’s instructions.
Western blot analysis. To determine plasma haptoglobin (Hp) and hemopexin (Hpx) levels, 5 µl sam-
ples of 20-fold diluted mouse blood plasma were resolved by electrophoresis on 8% SDS-PAGE gels. To anal-
syse LDH2 levels, 7 µl samples of 25-fold diluted mouse blood plasma were resolved by electrophoresis on 10% 
SDS-PAGE gels. Heme oxygenase 1 (HO1) and Slc48a1/HRG1 proteins were detected in 40 µg of membrane 
extracts (prepared as described previously37) following electrophoresis on non-denaturing 10% SDS-PAGE gels. 
Electroblotting of the resolved proteins onto PVDF membrane (Millipore), blocking and incubation with primary 
antibodies were performed as described previously37. The primary and secondary antibodies used for immunob-
lotting experiments are described in Table S1. For quantitative analysis of protein content, reactive bands were 
quantified relative to those of albumin or actin using a Molecular Imager with Quantity One software (Bio-Rad).
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Real-time quantitative RT-PCR. Total RNA was isolated from kidneys and livers of experimental ani-
mals using an RNA isolation kit (Macherey-Nagel). The RNA was treated with DNAse-I (Macherey-Nagel) and 
reverse transcribed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). A specific 
Hmox1 and Hamp fragments were then PCR amplified from this cDNA using the specific primers (Table S2). 
To evaluate the relative expression level compared to Actb, the deltadelta cT method was used. Real time qPCR 
was performed with the SybrGreen quantitative PCR kit (Applied Biosystems) using a StepOne thermocycler 
(Applied Biosystems).
Immunofluorescence (IF) analysis and confocal microscopy of liver and kidney sections. After 
laparotomy, mouse livers and kidneys were immediately dissected and fixed in 4% paraformaldehyde (Sigma) in 
phosphate-buffered saline (PBS) at 4 °C for 24 h. Following two 30 min washes in PBS, the tissues were succes-
sively soaked in 12.5 and 25% sucrose (Bioshop) for 2 h and 7 days, respectively, at 4 °C. Hepatic and renal samples 
were then embedded in Cryomatrix medium (Thermo Scientific), frozen in liquid nitrogen and sectioned in 
20-μm slices using a cryomicrotome (Shandon). The sections were washed in PBS for 10 min and permeabilized 
by bathing in PBS/0.1% Triton X-100 (Sigma) for 20 min. Non-specific antibody binding was blocked by incu-
bating the tissue sections in PBS/3% BSA (Bioshop) for 1.5 h. For protein detection, sections were incubated 
overnight at room temperature with primary antibodies diluted in PBS/3% BSA. As a negative control, some 
sections were incubated without primary antibody. The primary and fluorochrome-conjugated secondary anti-
bodies used in IF analysis are described in Supplementary Table S3. Next, the sections were washed for 5 × 6 min 
with PBS/0.1% Triton X-100 and incubated for 1.5 h with secondary antibody diluted in PBS/3% BSA at RT. 
Finally, sections were washed for 10 min in PBS and mounted in Vectashield medium with DAPI (Vector Labs). 
The presence of HO1 and Fpn in Browicz-Kupffer cells (liver macrophages) was determined by double immuno-
fluorescence localization of the investigated proteins and the macrophage marker F4/80. In order to distinguish 
the different proteins in this experiment, the secondary antibodies were conjugated with different fluorochromes: 
Cy3 for HO1/Fpn and Alexa488 for marker F4/80. For the immunolocalization of HO1 and F4/80, the standard 
IF protocol was performed using mixtures of the required primary and secondary antibodies. For the immu-
nolocalization of Fpn and F4/80, liver sections were first incubated with anti-Fpn and then with anti-F4/80 pri-
mary antibodies, then they were incubated with the mixture of secondary antibodies. The presence of HO1 and 
HRG1 in kidney was determined by double immunofluorescence localization of the investigated proteins and 
the marker AQP1, using secondary antibodies conjugated with different fluorochromes. Because the primary 
antibodies for the investigated proteins and for marker AQP1 were produced in the same host (rabbit), a protocol 
for fluorochrome-conjugated AffiniPure Fab fragments (Jackson Immunoresearch) was used for blocking and 
labelling primary antibodies. Monovalent Fab fragments of affinity-purified secondary antibodies were used to 
block the surface of specific primary antibodies. Because each labelled Fab fragment has only a single antigen 
binding site this prevents cross-reaction between the different secondary antibodies. HO1 and HRG1 were bound 
with primary antibodies, and these were then both blocked and labelled with Cy3-conjugated Fab fragments. 
Subsequently, the marker protein AQP1 was localized with primary antibodies and labelled with a standard diva-
lent Alexa488-conjugated secondary antibody. IF was analyzed with a Zeiss LSM 710 confocal microscope (Carl 
Zeiss) using a ×40 objective and Zeiss ZEN software.
Histological analysis of liver sections. Following fixation in Bouin’s solution for 24 h, livers were stored 
in 70% ethanol before further preparation. The tissue was embedded in paraffin and 7-μm cross-sections were cut 
through liver lobes with a microtome (Reichert-Jung, Germany). The sections were stained with hematoxylin and 
eosin. Slides were examined by light microscopy (Olympus, type CH2).
Renal iron staining. Non-heme iron deposits were analyzed using an Accustain Iron Deposition Kit (Sigma 
Aldrich). Briefly, kidney samples were excised immediately after sacrifice, fixed in Bouin’s solution for 24 h, then 
stored in 70% ethanol. After embedding in paraffin, the samples were cut into 7-μm sections using a microtome 
(Reichert-Jung, Germany). The sections were placed on a slide, deparaffinised and hydrated tissues were incu-
bated with a working solution containing Perls’ Prussian Blue for 30 min. Then counterstained with pararosani-
line solution for 2 min and analyzed by standard light microscopy (Olympus, type CH2).
ImageJ analysis of immunofluorescence images. ImageJ analysis was performed to characterize 
immunofluorescence produced using the ferroportin antibody. Samples from each group of animals were pre-
pared for analysis at the same time. Kidney sections from 3 different individuals per age group were examined by 
confocal microscopy at 40× magnification. For quantitative comparisons between age groups, the same acquisi-
tion parameters were applied to images within the same experimental set. Subsequently, ImageJ software (NIH, 
Bethesda) was used to measure mean fluorescence in each tubule section. The signal intensity was manually 
quantified to generate a Mean Gray Value: the sum of grey values in the selected area divided by the number of 
pixels within that area. For each experimental group, 30 measurements of cortical renal tubules were made (10 
measurements per individual).
Statistical analysis. Data were analyzed for normal distribution using Shapiro–Wilk test. Differences 
between groups were compared by parametric, two-tailed ANOVA tests or non-parametric, two-tailed 
Kruskal-Wallis ANOVA tests combined with proper post-hoc tests (Tukey test and Dunn test, respectively). A 
value of p < 0.05 being considered as statistically significant.
1 4Scientific RepoRtS |         (2019) 9:11102  | https://doi.org/10.1038/s41598-019-47414-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Data Availability
The datasets generated and analyzed during the current study are available from the corresponding author on 
reasonable request.
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